Klatzmann D - Search Results

1

A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma.

Klatzmann D, Valéry CA, Bensimon G, Marro B, Boyer O, Mokhtari K, Diquet B, Salzmann JL, Philippon J. Klatzmann D, et al. Hum Gene Ther. 1998 Nov 20;9(17):2595-604. doi: 10.1089/hum.1998.9.17-2595. Hum Gene Ther. 1998. PMID: 9853526 Clinical Trial.

2

[Treatment of experimental liver tumors by in vivo suicide gene transfer in rats].

Panis Y, Caruso M, Houssin D, Andreoletti M, Khayat D, Salzmann JL, Klatzmann D. Panis Y, et al. Among authors: klatzmann d. C R Acad Sci III. 1992;315(13):541-4. C R Acad Sci III. 1992. PMID: 1338622 French.

3

A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice.

Salomon B, Maury S, Loubière L, Caruso M, Onclercq R, Klatzmann D. Salomon B, et al. Among authors: klatzmann d. Mol Cell Biol. 1995 Oct;15(10):5322-8. doi: 10.1128/MCB.15.10.5322. Mol Cell Biol. 1995. PMID: 7565681 Free PMC article.

4

Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription.

Caruso M, Salomon B, Zhang S, Brisson E, Clavel F, Lowy I, Klatzmann D. Caruso M, et al. Among authors: klatzmann d. Virology. 1995 Jan 10;206(1):495-503. doi: 10.1016/s0042-6822(95)80065-4. Virology. 1995. PMID: 7831805 Free article.

5

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.

Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Caruso M, et al. Among authors: klatzmann d. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7024-8. doi: 10.1073/pnas.90.15.7024. Proc Natl Acad Sci U S A. 1993. PMID: 8346212 Free PMC article.

6

Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes.

Salmon P, Boyer O, Lorès P, Jami J, Klatzmann D. Salmon P, et al. Among authors: klatzmann d. J Immunol. 1996 Mar 1;156(5):1873-9. J Immunol. 1996. PMID: 8596039

7

Plasmoviruses: nonviral/viral vectors for gene therapy.

Noguiez-Hellin P, Meur MR, Salzmann JL, Klatzmann D. Noguiez-Hellin P, et al. Among authors: klatzmann d. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4175-80. doi: 10.1073/pnas.93.9.4175. Proc Natl Acad Sci U S A. 1996. PMID: 8633036 Free PMC article.

8

[Generation of a trans-complementable defective recombinant provirus and loading a transgene].

Noguiez-Hellin P, Robert-Le Meur M, Laune S, Salzmann JL, Klatzmann D. Noguiez-Hellin P, et al. Among authors: klatzmann d. C R Acad Sci III. 1996 Jan;319(1):45-50. C R Acad Sci III. 1996. PMID: 8673619 French.

9

Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect".

Gagandeep S, Brew R, Green B, Christmas SE, Klatzmann D, Poston GJ, Kinsella AR. Gagandeep S, et al. Among authors: klatzmann d. Cancer Gene Ther. 1996 Mar-Apr;3(2):83-8. Cancer Gene Ther. 1996. PMID: 8729906

10

Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.

Klatzmann D. Klatzmann D. Hum Gene Ther. 1996 Jan 20;7(2):255-67. doi: 10.1089/hum.1996.7.2-255. Hum Gene Ther. 1996. PMID: 8788175 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters